News

December 10, 2015 10:15 am
The IMF team brings you all the latest news from the 2015 Annual Meeting of the American Society of Hematology (ASH) from Dec. 5th to Dec. 8th in Orlando, FL. Tune into our comprehensive updates via blogs, Facebook, Twitter and IMF-TV to learn about...
December 10, 2015 10:00 am
Dr. Brian Durie discussed the randomized phase 3 SWOGG S0777 trial that investigated the addition of bortezomib to lenalidomide and dexamethasone for previously untreated multiple myeloma patients without an intend for immediate autologous stem cell...
December 10, 2015 10:00 am
A SWOG trial shows bortezomib, lenalidomide, and dexamethasone delays recurrence and lengthens life for myeloma patients, indicating a possible new standard of care.

Pages